EVALUATION INSTRUMENTS: A participant identification form will be filled out, containing full name, date of birth, gender, address, telephone number, education, diagnosis, time of diagnosis, onset of symptoms (laterality), associated diseases, PD subtype and medicines.

The study will consist of two groups: intervention group (IG), which will receive treatment with Leap Motion Controller and the control group (CG), who will receive treatment with conventional physiotherapy. Do not perform / abstain from two appointments out of the 16 proposed in the intervention protocol, regardless of the group that will be allocated. Individuals who: - Do not show the understanding of the games on the first day of familiarization - Have a cerebral pacemaker implant - Have recent injuries or limitations that make the MMSS impossible. Have signed the informed consent form (Appendix A). Residents in the city of Porto Alegre / RS.

Individuals who: - are diagnosed with Parkinson's disease - Classified as I-III on the Hoehn & Yahr motor staging scale - Are over 18 years old (above this, without age restriction). PARTICIPANTS: Participants will be recruited from an existing pre-existing list of research conducted on individuals with Parkinson's Disease from the UFCSPA.LOCATION: The place where the entire study will be carried out will be in the home environment of each research participant.Area: Physiotherapy and Occupational Therapy. AREA OF SCOPE: Major area: Health Sciences.TYPE OF STUDY: Randomized Clinical Trial.The sample will be probabilistic, from individuals diagnosed with Parkinson's disease. RESEARCH DESIGN: The proposed work will be characterized as a Randomized Clinical Trial, with evaluators outside the experimental groups (single-blind).

Why Should I Register and Submit Results?.

Iclone leap motion